Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol monotherapy in heart failure with recovered ejection fraction
RBR-75jm4cjPhase 2Recruiting
- Sponsor
- INCOR
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carvedilol in heart failure (HF) and left ventricular systolic dysfunction (LVSD) (2 arms), sponsored by INCOR. Started Apr 2022; status: recruiting.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on RBR-75jm4cj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-75jm4cj.